ClinicalTrials.Veeva

Menu

Bicarbonate Epidural Injection in Emergency Caesarian (BiEpIC)

C

CHU de Reims

Status and phase

Completed
Phase 3

Conditions

Emergency Caesarean

Treatments

Drug: 2% adrenaline lidocaine associated with 4.2% sodium bicarbonate
Drug: 2% adrenaline lidocaine

Study type

Interventional

Funder types

Other

Identifiers

NCT04255121
PO19144*

Details and patient eligibility

About

During labor, pain is systematic. In France, epidural analgesia is the gold standard to fight pain.

Sometimes, emergency situations involve the maternal or fetal prognosis and require an emergency fetal extraction by caesarean. When an effective epidural analgesia is in place, an injection of adrenaline lidocaine converts this epidural analgesia into an epidural anesthesia allowing a surgical procedure. Sometimes, the time required to set up the anesthesia cannot be expected and a general anesthesia is performed.

Local anesthetics used during epidural analgesia have Pka between 7.8 and 8.1. In solution, local anesthetics exist in two forms: an un-ionized form and an ionized form. The non-ionized form is liposoluble and crosses the lipid membranes to reach the site of intracellular action. The non-ionized form conditions the time taken to install anesthesia.

When the pH of the solution is equal to Pka, un-ionized and ionized form are present in equal quantity. Commercial local anesthetic solutions have acidic pH and so contained a majority of ionized form. Alkalinization of local anesthetics solution should bring the pH closer to pKa and therefore to favor a greater proportion of non-ionized form.

Full description

The aim of this study is to evaluate impact of an alkalinization of adrenaline lidocaine solution for conversion of epidural analgesia into epidural anesthesia during an emergency caesarean.

Enrollment

400 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • pregnant women followed up in the Reims University Hospital
  • women whose birth is expected by vaginal delivery in the Reims University Hospital
  • women wishing to benefit from epidural analgesia
  • women agreeing to participate in the research and having signed informed consent
  • women aged 18 years old and more
  • women affiliated to a social security system

Exclusion criteria

  • women who don't benefit from emergency caesarian (vaginal delivery or scheduled caesarian)
  • women for whom epidural analgesia cannot be used
  • women for whom epidural analgesia is not effective

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

400 participants in 2 patient groups

alkalinization of adrenaline lidocaine solution arm
Experimental group
Description:
conversion of epidural analgesia into epidural anesthesia during an emergency caesarean using an alkalinization of adrenaline lidocaine solution
Treatment:
Drug: 2% adrenaline lidocaine associated with 4.2% sodium bicarbonate
adrenaline lidocaine solution arm
Active Comparator group
Description:
conversion of epidural analgesia into epidural anesthesia during an emergency caesarean using a adrenaline lidocaine solution
Treatment:
Drug: 2% adrenaline lidocaine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems